MSrelapsing multiple sclerosisSPDMTs
… A cohort study on prospectively acquired data from the Italian MS register. The primary outcome was to describe the MS disease co…
112articles mentioning diseases
459disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: MS ×
MS
This disease is selected. Its supporting articles are shown below.
Articles mentioning MS
112 articles · page 7 of 10Multiple sclerosisMS
…Objective Multiple sclerosis (MS) is a neurodegenerative disease that affects young people a…
multiple sclerosisMSinfectious mononucleosis
…Background Benign multiple sclerosis (MS), characterised by minimal disability despite long disease …
multiple sclerosisMScraniosacral therapyconventional physiotherapy
… (CST) on pain, autonomic dysfunction and symptom management in multiple sclerosis (MS) patients.Methods Twenty MS patients (CST group n=10, contr…
multiple sclerosisMS
…to the McDonald criteria mark a major shift in the diagnosis of multiple sclerosis (MS), reflecting advances in imaging and biomarker science. The…
multiple sclerosisspastic quadriplegiaMSADIntrathecal baclofen
…echanical or hardware complications. We describe a patient with multiple sclerosis (MS) and spastic quadriplegia who underwent ITB pump implantati…
MSrelapsing-remitting multiple sclerosisnatalizumab
…pport sustainable decision making and improve patient access in MS care.Conflict of Interest No conflict of interest…
MSlevofloxacinmetronidazolemoxifloxacinlinezolidvoriconazoledoxycyclineclindamycinazithromycinfluconazole
…idazole (14.4%), clindamycin (13.6%), and linezolid (13.2%). In MS, follow-up was achieved in 124 cases; 79% were accepted. Ciprof…
multiple sclerosisMSSPMSRRMSofatumumabocrelizumabteriflunomidenatalizumab
… all patients with relapsing-remitting or secondary progressive multiple sclerosis (RRMS; SPMS), who initiated Ofatumumab between January 2023 and…
multiple sclerosisMSPIRAnatalizumabFlorenceNTZNTZ-oDMTs
…ependent of relapse activity (PIRA) is a relevant unmet need in multiple sclerosis (MS), being only modestly affected by disease-modifying treatme…
multiple sclerosisMSteriflunomidefingolimodinterferon betaglatiramer acetateocrelizumabrituximabdimethyl fumarate
…valuating the efficacy of disease-modifying therapies (DMTs) in multiple sclerosis (MS) using French registry data.Methods This multicentre, retro…
myelin oligodendrocyte glycoprotein antibody-associated diseasemultiple sclerosisneuromyelitis optica spectrum diseaseNMOSDMOGADautoimmune glial fibrillary acidic protein astrocytopathyclinically isolated syndromeMSNIDBaseelectrical stimulation therapies
… sclerosis (MS), neuromyelitis optica spectrum disease (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and autoimmune glial fibrillary acidic protein astrocyt…